Femasys (FEMY) Change in Account Payables (2020 - 2026)
Femasys (FEMY) reported Change in Account Payables of -$253439.0 for Q1 2026, down 128.45% on a YoY basis from $890678.0 in Q1 2025, and up 21.19% quarter-over-quarter from -$321574.0 in Q4 2025.
Femasys (FEMY) Change in Account Payables (2020 - 2026) Analysis & Trends
Femasys has reported Change in Account Payables for 7 years, with the latest figure at -$253439.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 128.45% year-over-year to -$253439.0; the trailing twelve-month figure through Mar 2026 stood at -$809288.0 (down 165.48% YoY), and the FY2025 full-year result was $334829.0, up 61.38% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$253439.0, up from -$321574.0 in the prior quarter.
- The five-year high for Change in Account Payables was $890678.0 in Q1 2025, with the low at -$1.1 million in Q3 2025.
- Historically, Change in Account Payables has averaged $57716.0 across 5 years, with a median of $33103.0 in 2023.
- Annual changes were most pronounced in 2022 — Change in Account Payables jumped 1228.6% — and 2024, when it sank 4667.41%.
- Femasys' Change in Account Payables stood at $114685.0 in 2022, then surged by 149.33% to $285946.0 in 2023, then declined by 9.33% to $259280.0 in 2024, then plunged by 224.03% to -$321574.0 in 2025, then climbed by 21.19% to -$253439.0 in 2026.
- The last three Change in Account Payables figures came in at -$253439.0 (Q1 2026), -$321574.0 (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 73.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 6.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 23.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 4.93 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 102.00 Mn |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | -253,439.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -253,439.00 |
| Mar 31, 2026 | -253,439.00 |
| Dec 31, 2025 | -321,574.00 |
| Dec 31, 2025 | -321,574.00 |
| Sep 30, 2025 | -1.10 Mn |
| Sep 30, 2025 | -1.10 Mn |
| Jun 30, 2025 | 867,484.00 |
| Jun 30, 2025 | 867,484.00 |
| Mar 31, 2025 | 890,678.00 |
| Mar 31, 2025 | 890,678.00 |
| Dec 31, 2024 | 259,280.00 |
| Dec 31, 2024 | 259,280.00 |
| Sep 30, 2024 | 171,883.00 |
| Sep 30, 2024 | 171,883.00 |
| Jun 30, 2024 | -85,929.00 |
| Jun 30, 2024 | -85,929.00 |
| Mar 31, 2024 | -137,753.00 |
| Mar 31, 2024 | -137,753.00 |
| Dec 31, 2023 | 285,946.00 |
| Dec 31, 2023 | 285,946.00 |